Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873725 | 0.97 | TSHR (0.45) | ALDH1A1TSHRHTTLMNAABCC4 | |
| Boric Acid SCHEMBL28756071 | 0.87 | ALDH1A1 (0.39) | ALDH1A1TSHRHTT | |
| Lithium Ion SCHEMBL28756070 | 0.84 | ALDH1A1 (0.37) | ALDH1A1TSHRHTT | |
| SCHEMBL11131461 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRHTTKMT2A | |
| SCHEMBL10544728 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRHTTMAPT | |
| SCHEMBL462608 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRHTT | |
| SCHEMBL8815411 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TSHRHTTLMNAABCC4 | |
| SCHEMBL8411060 | 0.82 | ALDH1A1 (0.36) | ALDH1A1TSHRHTTKMT2A | |
| SCHEMBL17975859 | 0.80 | ALDH1A1 (0.38) | ALDH1A1TSHRHTT | |
| SCHEMBL9413907 | 0.80 | ALDH1A1 (0.38) | ALDH1A1TSHRHTTABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9803098-B2 | Conductive ink | PESOLVE CO., LTD. (KR) | 2017-10-31 | — | — | US | disclosed |
| US-9683123-B2 | Silver ink | PESOLVE CO., LTD. (KR) | 2017-06-20 | — | — | US | disclosed |
| US-20160185990-A1 | CONDUCTIVE INK | YMT CO.,LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160168408-A1 | SILVER INK | PESOLVE CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168408-A1 | SILVER INK | TP53, MKI67, NRAS | ALDH1A1 23/4885TSHR 4766/4885HTT 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.